OFI Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

OFI Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,184	Closed	-$205K	–	1745
2015 Q1	$205K	Sell	1,184 -828	-41%	-$122K	0.01%	1232
2014 Q4	$231K	Buy	2,012 +658	+49%	+$79.7K	0.01%	1128
2014 Q3	$212K	Sell	1,354 -332	-20%	-$48.1K	0.02%	1113
2014 Q2	$208K	Buy	1,686 +348	+26%	+$38.5K	0.01%	1137
2014 Q1	$139K	Sell	1,338 -23	-2%	-$2.35K	0.01%	1297
2013 Q4	$122K	Sell	1,361 -11	-0.8%	-$877	0.01%	1346
2013 Q3	$92K	Sell	1,372 -1,939	-59%	-$134K	0.01%	1363
2013 Q2	$219K	Buy	+3,311	New	+$189K	0.02%	826

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

OFI Advisors's SLXP Position: Q2 2015 in Review

OFI Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,184 shares — an estimated $205K sold.

OFI Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $231K in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

OFI Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
OFI Advisors sold 1,184 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $205K.
OFI Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
OFI Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $231K in Q4 2014.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on OFI Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.